$25.44
-0.06 (-0.24%)
Open$25.32
Previous Close$25.50
Day High$25.80
Day Low$25.01
52W High$28.23
52W Low$8.20
Volume—
Avg Volume1.26M
Market Cap2.61B
P/E Ratio—
EPS$-3.45
SectorBiotechnology
Analyst Ratings
Strong Buy
21 analysts
Price Target
+184.2% upside
Current
$25.44
$25.44
Target
$72.29
$72.29
$45.76
$72.29 avg
$82.91
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 100.76M | 77.79M | 234.23M |
| Net Income | -317,310,235 | -220,456,393 | -24,379,697 |
| Profit Margin | -314.9% | -299.2% | -10.4% |
| EBITDA | -332,274,167 | -243,677,982 | -31,389,191 |
| Free Cash Flow | — | — | -25,443,977 |
| Rev Growth | +29.5% | +29.5% | +16.3% |
| Debt/Equity | — | — | 0.64 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |